The COVID-19 pandemic and its impact on the development of gestational diabetes mellitus (GDM) in West Virginia
Copyright © 2024 Elsevier B.V. All rights reserved..
OBJECTIVE: To examine the rate of gestational diabetes mellitus (GDM) prevalence before and during the COVID-19 pandemic.
RESULTS: Analysis revealed that GDM prevalence was significantly higher during the COVID-19 pandemic compared to pre-pandemic (8.59 % vs 7.77 %). The risk of GDM was 12 % higher during the pandemic vs. pre-pandemic (aRR = 1.12, 95 % CI 1.06, 1.19) and the aRD = 0.95 % (95 % CI 0.56 %, 1.33 %) adjusting for maternal age and substance use in pregnancy.
CONCLUSIONS: GDM rates in WV increased from the period directly before the COVID-19 pandemic to during the COVID-19 pandemic. More research is needed to understand the pathophysiological mechanisms of pandemics and pandemic-related risk factors for this observed association. Supporting pregnant individuals during such events is critical to both maternal and child health.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:208 |
|---|---|
| Enthalten in: |
Diabetes research and clinical practice - 208(2024) vom: 03. Feb., Seite 111126 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Garrow, Jana [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Appalachia |
|---|
| Anmerkungen: |
Date Completed 19.02.2024 Date Revised 19.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.diabres.2024.111126 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368191508 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368191508 | ||
| 003 | DE-627 | ||
| 005 | 20240219232038.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240209s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.diabres.2024.111126 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1299.xml |
| 035 | |a (DE-627)NLM368191508 | ||
| 035 | |a (NLM)38311246 | ||
| 035 | |a (PII)S0168-8227(24)00039-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Garrow, Jana |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The COVID-19 pandemic and its impact on the development of gestational diabetes mellitus (GDM) in West Virginia |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.02.2024 | ||
| 500 | |a Date Revised 19.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 Elsevier B.V. All rights reserved. | ||
| 520 | |a OBJECTIVE: To examine the rate of gestational diabetes mellitus (GDM) prevalence before and during the COVID-19 pandemic | ||
| 520 | |a RESULTS: Analysis revealed that GDM prevalence was significantly higher during the COVID-19 pandemic compared to pre-pandemic (8.59 % vs 7.77 %). The risk of GDM was 12 % higher during the pandemic vs. pre-pandemic (aRR = 1.12, 95 % CI 1.06, 1.19) and the aRD = 0.95 % (95 % CI 0.56 %, 1.33 %) adjusting for maternal age and substance use in pregnancy | ||
| 520 | |a CONCLUSIONS: GDM rates in WV increased from the period directly before the COVID-19 pandemic to during the COVID-19 pandemic. More research is needed to understand the pathophysiological mechanisms of pandemics and pandemic-related risk factors for this observed association. Supporting pregnant individuals during such events is critical to both maternal and child health | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Appalachia | |
| 650 | 4 | |a Coronavirus | |
| 650 | 4 | |a Covid-19 | |
| 650 | 4 | |a Gestational Diabetes | |
| 650 | 4 | |a West Virginia | |
| 700 | 1 | |a Fan, Isadora |e verfasserin |4 aut | |
| 700 | 1 | |a Lilly, Christa |e verfasserin |4 aut | |
| 700 | 1 | |a Lefeber, Candice |e verfasserin |4 aut | |
| 700 | 1 | |a Barone Gibbs, Bethany |e verfasserin |4 aut | |
| 700 | 1 | |a Lefeber, Timothy |e verfasserin |4 aut | |
| 700 | 1 | |a John, Collin |e verfasserin |4 aut | |
| 700 | 1 | |a Umer, Amna |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Diabetes research and clinical practice |d 1993 |g 208(2024) vom: 03. Feb., Seite 111126 |w (DE-627)NLM01260335X |x 1872-8227 |7 nnns |
| 773 | 1 | 8 | |g volume:208 |g year:2024 |g day:03 |g month:02 |g pages:111126 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.diabres.2024.111126 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 208 |j 2024 |b 03 |c 02 |h 111126 | ||